Clinical Trials

70 enrolled

Stomach Neoplasms

NCT05636150 2022-12-05

A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma

48 enrolled

Esophageal Squamous Cell Carcinoma

NCT05627414 2022-11-25

Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer

Stomach Neoplasms

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

45 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03946969 2022-07-19

Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05441254 2022-07-08

Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis：Single-arm, Prospective Clinical Study

33 enrolled

Stage IV Gastric Cancer With Metastasis

NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

46 enrolled

Advanced Gastric Adenocarcinoma

NCT05218148 2022-04-06

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

GastrointestinalOther solid neoplasm

44 enrolled

HER2-positive

NCT05228743 2022-02-08

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

180 enrolled

Stomach Neoplasms

NCT04062058 2022-01-24

A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

82 enrolled

Stomach Neoplasms

NCT05204173 2022-01-24

Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis

Stomach Neoplasms

NCT03801668 2022-01-04

Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

Phase 3 Unknown

294 enrolled

Stomach Neoplasms

NCT05138159 2021-11-30

A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen

10 enrolled

Pancreatic Neoplasms

NCT05111444 2021-11-08

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

65 enrolled

Stomach Neoplasms

NCT04982939 2021-08-31

Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer

210 enrolled

Stomach Neoplasms

NCT03961867 2021-06-01

Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma

Phase 3 Unknown

440 enrolled

Stomach Neoplasms

NCT04781686 2021-05-17

Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer

35 enrolled

Metastatic Gastric Adenocarcinoma

NCT04886193 2021-05-13

FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT03403101 2021-04-09

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

65 enrolled

Carcinoma, Pancreatic Ductal

NCT04808687 2021-03-22

Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer

72 enrolled

Pancreatic Neoplasms

NCT04781413 2021-03-04

Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Phase 1/2 Unknown

38 enrolled

Stomach Neoplasms

NCT03986294 2021-01-15

NAPAN

122 enrolled

Pancreatic Neoplasms

NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

200 enrolled

Thoracic

Advanced NSCLC With EGFR Mutation

NCT04377048 2020-05-06

Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

38 enrolled

Pancreatic Neoplasms

NCT04367025 2020-04-29

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

70 enrolled

Stomach Neoplasms

NCT04152889 2020-04-20

A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Stomach Neoplasms

NCT03397199 2020-04-15

Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer

120 enrolled

Colorectal Neoplasms

NCT04135781 2020-03-23

Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

Phase 3 Unknown

616 enrolled

Stomach Neoplasms

NCT04274270 2020-03-19

SBRTLCES

60 enrolled

Thoracic

Lung Neoplasms, Radiation Injuries

NCT03850769 2020-03-10

Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer

60 enrolled

Borderline Resectable Pancreatic Cancer

NCT03885219 2020-03-10

Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer

60 enrolled

Locally Advanced Pancreatic Cancer

NCT04258657 2020-02-06

Neoadjuvant Chomotherapy With Paclitaxel-albumin and S-1 for Advanced Gastric Cancer

Stomach Neoplasms

NCT04217096 2020-01-03

Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients

Phase 4 Unknown

40 enrolled

Advanced Pancreatic Cancer

NCT04101929 2019-11-05

Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen

126 enrolled

Pancreatic Neoplasms

NCT04027764 2019-07-22

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

NCT03263741 2019-07-08

Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer